Shots:
- The US FDA has granted 510(k) clearance to two AI algorithm enhancements, Epileptiform Abnormality Detection & Artifact Reduction, which are integrated into its cloud-based Neurology Portal
- The Artifact Reduction algorithm identifies interference from patient movement, medical equipment, and physiological signals, while Epileptiform Abnormality Detection flags abnormal patterns across lengthy EEG recordings, helping neurologists navigate complex ictal-interictal findings more efficiently
- Built on more than 1M hrs. of EEG data, the enhancements require no software downtime or installation & complement Ceribell’s POC system, which can initiate bedside monitoring in as little as 5min.
Ref: Globenewswire | Image: Ceribell | Press Release
PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com
